Andrew Nicklawsky
Overview
Explore the profile of Andrew Nicklawsky including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
32
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Batta N, Shangraw S, Nicklawsky A, Yamauchi T, Zhai Z, Ravindran Menon D, et al.
JMIR Dermatol
. 2022 Aug;
4(2):e31275.
PMID: 35990801
No abstract available.
12.
Schreiber A, Kagihara J, Weiss J, Nicklawsky A, Gao D, Borges V, et al.
Front Oncol
. 2021 Apr;
11:640690.
PMID: 33816286
Background: Immuno-oncology (IO) agents have demonstrated efficacy across many tumor types and have led to change in standard of care. In breast cancer, atezolizumab and pembrolizumab were recently FDA-approved in...
13.
Shay R, Nicklawsky A, Gao D, Lam E
Clin Genitourin Cancer
. 2021 Mar;
19(4):370-370.e7.
PMID: 33674224
Background: There now exist several viable first-line treatment options for metastatic renal cell carcinoma, making the choice of initial therapy difficult. Considering metrics other than patient factors may be necessary...
14.
Stoen E, Kagihara J, Shagisultanova E, Fisher C, Nicklawsky A, Kabos P, et al.
Breast Cancer Res Treat
. 2021 Feb;
187(3):883-891.
PMID: 33625615
Purpose: Adjuvant pertuzumab and neratinib are independently FDA-approved for treatment of early-stage HER2-positive breast cancer in combination with or following trastuzumab for one year, respectively. Both agents reduce the risk...
15.
Weiss J, Nicklawsky A, Kagihara J, Gao D, Fisher C, Elias A, et al.
Cancer Med
. 2020 Oct;
9(23):8801-8808.
PMID: 33063469
Patients with metastatic breast cancer (MBC) refractory to standard of care therapies have a poor prognosis. The purpose of this study was to assess patient characteristics and clinical outcomes for...
16.
Patel S, Ahnen D, Gumidyala A, Espinoza J, Nicklawsky A, Hu J, et al.
Dig Dis Sci
. 2020 Mar;
65(9):2542-2550.
PMID: 32144601
Background And Aims: Advanced colorectal polyps (adenoma or sessile serrated polyp ≥ 1 cm, adenoma with villous features, adenoma with high-grade dysplasia, or any sessile serrated polyps with dysplasia) are...